Compounds > mitomycin
Page last updated: 2024-08-16

mitomycin and vorinostat

mitomycin has been researched along with vorinostat in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Agarawal, A; Kharya, MD; Parmar, P; Rajak, H; Sharma, PC; Thakur, BS; Veerasamy, R1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jeong, WJ; Kim, SW; Kim, TH; Lee, DJ; Park, JM; Park, WC; Rho, JH; Rho, SH; Woo, JM; Yoo, YH1
Beck, JF; Bröker, BM; Friebe, E; Schmudde, M; Sonnemann, J1
Ahn, HB; Jeung, WJ; Kim, TH; Oh, HC; Park, WC; Rho, JH; Rho, SH; Yoo, YH1
Kim, SW; Park, WC; Woo, JE; Yoo, YH1
Anumanthan, G; Gupta, S; Hamm, CW; Hesemann, NP; Mohan, RR; Sharma, A; Waggoner, M1
Dadachanji, ZV; Das, D; Ghosh, A; Khamar, P; Krishna, L; Kumar, NR; Matalia, H; Mohan, RR; Murugeswari, P; Shetty, R; Subramani, M1

Reviews

1 review(s) available for mitomycin and vorinostat

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for mitomycin and vorinostat

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19

    Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Proliferation; Drug Design; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Neoplasms; Oxadiazoles; Structure-Activity Relationship; Surface Properties; Thiadiazoles; Zinc

2011
Co-treatment of suberoylanilide hydroxamic acid and mitomycin-C induces the apoptosis of rabbit tenon's capsule fibroblast and improves the outcome of glaucoma filtration surgery.
    Current eye research, 2008, Volume: 33, Issue:3

    Topics: Alkylating Agents; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Caspase 3; Cell Culture Techniques; Connective Tissue Cells; Drug Therapy, Combination; Enzyme Inhibitors; Fibroblasts; Fibrosis; Filtering Surgery; Fluorescent Antibody Technique, Indirect; Glaucoma; Histone Deacetylase Inhibitors; Hydroxamic Acids; In Situ Nick-End Labeling; Intraocular Pressure; Mitomycin; Phosphorylation; Rabbits; Surgical Flaps; Tumor Suppressor Protein p53; Up-Regulation; Vorinostat

2008
Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions.
    Cancer letters, 2010, Sep-28, Volume: 295, Issue:2

    Topics: Apoptosis; B7-2 Antigen; Cell Line, Tumor; Cytotoxicity, Immunologic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Mitomycin; T-Lymphocytes; Vorinostat

2010
An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with mitomycin-C and a histone deacetylase inhibitor.
    Archives of pharmacal research, 2010, Volume: 33, Issue:8

    Topics: Alkylating Agents; Animals; Apoptosis; Cells, Cultured; Conjunctiva; Drug Therapy, Combination; Epithelial Cells; Fibroblasts; Fibrosis; Filtering Surgery; Glaucoma; Histone Deacetylase Inhibitors; Hydroxamic Acids; L-Lactate Dehydrogenase; Mitomycin; Rabbits; Reactive Oxygen Species; Tenon Capsule; Vorinostat

2010
The efficacy of co-treatment with suberoylanilide hydroxamic acid and mitomycin C on corneal scarring after therapeutic keratectomy: an animal study.
    Current eye research, 2014, Volume: 39, Issue:4

    Topics: Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Cicatrix; Corneal Diseases; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Epithelium, Corneal; Fibrosis; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mitomycin; Nucleic Acid Synthesis Inhibitors; Photorefractive Keratectomy; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vorinostat

2014
Efficacy and Safety Comparison Between Suberoylanilide Hydroxamic Acid and Mitomycin C in Reducing the Risk of Corneal Haze After PRK Treatment In Vivo.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2017, Dec-01, Volume: 33, Issue:12

    Topics: Alkylating Agents; Animals; Apoptosis; Cornea; Corneal Opacity; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Histone Deacetylase Inhibitors; Hydroxamic Acids; In Situ Nick-End Labeling; Mitomycin; Photorefractive Keratectomy; Rabbits; Slit Lamp; Treatment Outcome; Vorinostat

2017
Safety and efficacy of combination of suberoylamilide hydroxyamic acid and mitomycin C in reducing pro-fibrotic changes in human corneal epithelial cells.
    Scientific reports, 2021, 02-23, Volume: 11, Issue:1

    Topics: Adult; Apoptosis; Cells, Cultured; Collagen Type IV; Epithelium, Corneal; Female; Fibrosis; Humans; Keratins; Male; Middle Aged; Mitomycin; Vorinostat

2021